ATRenew Inc. Sponsored ADR (NYSE:RERE - Free Report) - Equities researchers at Zacks Research reduced their FY2026 EPS estimates for shares of ATRenew in a research note issued on Friday, August 21st. Zacks Research analyst B. Lantier now forecasts that the company will earn $0.37 per share for the year, down from their prior forecast of $0.40. The consensus estimate for ATRenew's current full-year earnings is $0.40 per share. Zacks Research also issued estimates for ATRenew's Q1 2027 earnings at $0.10 EPS, Q2 2027 earnings at $0.11 EPS, Q3 2027 earnings at $0.12 EPS and Q4 2027 earnings at $0.13 EPS.
Several other brokerages have also recently issued reports on RERE. UBS Group assumed coverage on ATRenew in a research report on Tuesday, July 21st. They set a "buy" rating and a $5.50 price target on the stock. Wall Street Zen cut ATRenew from a "strong-buy" rating to a "buy" rating in a research note on Saturday, July 25th. CICC Research started coverage on ATRenew in a report on Thursday, August 20th. They set an "outperform" rating on the stock. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of ATRenew in a research report on Wednesday, July 29th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $5.50.
Read Our Latest Analysis on ATRenew
ATRenew Price Performance
Shares of NYSE:RERE opened at $4.00 on Thursday. The stock has a market cap of $877.60 million, a price-to-earnings ratio of 13.79 and a beta of 0.31. ATRenew has a 12 month low of $3.50 and a 12 month high of $6.47. The stock's 50 day moving average price is $4.10 and its 200 day moving average price is $4.64.
ATRenew (NYSE:RERE - Get Free Report) last issued its quarterly earnings results on Thursday, August 20th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.01. ATRenew had a net margin of 2.01% and a return on equity of 12.32%. The company had revenue of $972.82 million during the quarter, compared to analyst estimates of $930.34 million.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of RERE. Wellington Management Group LLP bought a new stake in shares of ATRenew during the 4th quarter worth $23,190,000. Price T Rowe Associates Inc. MD boosted its position in shares of ATRenew by 60.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,857,684 shares of the company's stock valued at $20,447,000 after purchasing an additional 1,450,764 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of ATRenew by 98.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,950,152 shares of the company's stock valued at $13,571,000 after purchasing an additional 1,466,383 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in ATRenew in the 4th quarter worth about $4,764,000. Finally, JPMorgan Chase & Co. increased its stake in ATRenew by 117.2% in the 4th quarter. JPMorgan Chase & Co. now owns 808,934 shares of the company's stock worth $4,287,000 after purchasing an additional 436,577 shares in the last quarter. Institutional investors own 19.29% of the company's stock.
ATRenew Company Profile
(
Get Free Report)
ATRenew Inc, through its subsidiaries, operates pre-owned consumer electronics transactions and services platform in the People's Republic of China. It primarily sells mobile phones, laptops, tablets, drones, digital cameras; and vintage bags, watches, liquor, gold, and various household goods through its online platforms and offline stores, as well as provides services to third-party merchants to sell the products through its platforms. The company was formerly known as AiHuiShou International Co Ltd.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider ATRenew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ATRenew wasn't on the list.
While ATRenew currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
